CSPCY (CSPC Pharmaceutical Group) Property, Plant and Equipment: $1,994 Mil (As of Dec. 2025)


CSPCY CSPC Pharmaceutical Group Ltd CSPCY
78 GF Score
Price $3.84
GF Value $3.16
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is CSPC Pharmaceutical Group Property, Plant and Equipment?

CSPC Pharmaceutical Group CSPCY +8.17% 78 Property, Plant and Equipment is $1,994 Mil as of Dec. 2025. GuruFocus rates CSPCY with a GF Score™ of 78/100 and a GF Value™ of $3.16 (Modestly Overvalued). The stock has 4 warning signs investors should review.

CSPC Pharmaceutical Group's quarterly net PPE declined from Jun. 2025 ($1,898 Mil) to Sep. 2025 ($0 Mil) but then increased from Sep. 2025 ($0 Mil) to Dec. 2025 ($1,994 Mil).

CSPC Pharmaceutical Group's annual net PPE increased from Dec. 2023 ($1,717 Mil) to Dec. 2024 ($1,796 Mil) and increased from Dec. 2024 ($1,796 Mil) to Dec. 2025 ($1,994 Mil).


CSPC Pharmaceutical Group  (OTCPK:CSPCY) Property, Plant and Equipment Explanation

A company with durable competitive advantage doesn't need to constantly upgrade its equipment to stay competitive. The company replaces when it wears out. On the other hand, a company without any advantages must replace to keep pace.

Difference between a company with a moat and one without is that the company with the competitive advantage finances new equipment through internal cash flows, whereas the no advantage company requires debt to finance.

Producing a consistent product that doesn't change equates to consistent profits. There is no need to upgrade plants which frees up cash for other ventures. Think Coca Cola, Johnson & Johnson etc.


CSPC Pharmaceutical Group Property, Plant and Equipment Related Terms


CSPC Pharmaceutical Group Property, Plant and Equipment Historical Data

* Premium members only.

The historical data trend for CSPC Pharmaceutical Group's Property, Plant and Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CSPC Pharmaceutical Group Property, Plant and Equipment Chart

CSPC Pharmaceutical Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Property, Plant and Equipment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,591.04 1,688.75 1,717.32 1,796.39 1,994.25

CSPC Pharmaceutical Group Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Property, Plant and Equipment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 1,898.30 0.00 1,994.25 0.00
CSPCY
78GF Score
CSPC Pharmaceutical Group Ltd CSPCY
Property, Plant and Equipment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CSPC Pharmaceutical Group Property, Plant and Equipment Calculation

Property, Plant and Equipment (PPE) are the fixed assets of the companyFixed assets are also known as non-current assets.

Property, plant, and equipment includes assets that will - in the normal course of business - neither be used up in the next year nor will become a part of any product sold to customers.

Some of the most common parts of property, plant, and equipment are:


Land
Buildings (and leasehold improvements)
Transportation equipment
Manufacturing equipment
Office equipment
Office furniture

Companies with lots of property, plant, and equipment often have special categories. For example, railroad property includes:


Track
Ties
Ballast
Bridges
Tunnels
Signals
Locomotives
Freight Cars

There is often a note in the financial statements - found in a company's 10-K - that will explain the different categories of property a company owns.

The market value of property, plant, and equipment can differ tremendously from the book value of property, plant, and equipment.

For example, when Berkshire Hathaway liquidated its textile mills, it had to pay the buyers of the company's manufacturing equipment to haul the equipment away. That property, plant, and equipment was literally worth less than zero. On the other hand, some companies own thousands of acres of land.

All property, plant, and equipment other than land is depreciated. Land is never depreciated. However, land is not marked up to market value either. Under Generally Accepted Accounting Principles (GAAP), land is shown on the balance sheet at cost.

The property, plant, and equipment line shown on the balance sheet is usually net property, plant, and equipment. This means it is the cost of the property, plant, and equipment less accumulated depreciation.

What does a Property, Plant and Equipment of $1,994 Mil mean?
CSPC Pharmaceutical Group (CSPCY) has a Property, Plant and Equipment of $1,994 Mil as of Dec. 2025. The total property, plant and equipment recorded on a company's balance sheet less accumulated depreciation. View historical data on CSPC Pharmaceutical Group and its competitors.
Is CSPC Pharmaceutical Group's Property, Plant and Equipment too high?
CSPC Pharmaceutical Group's current Property, Plant and Equipment is $1,994 Mil. Overall, CSPC Pharmaceutical Group has a GF Score™ of 78/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does CSPC Pharmaceutical Group's Property, Plant and Equipment compare to LLY and JNJ?
CSPC Pharmaceutical Group's Property, Plant and Equipment of $1,994 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Property, Plant and Equipment for a Drug Manufacturers company?
A good Property, Plant and Equipment depends on the Drug Manufacturers industry context. However, Property, Plant and Equipment should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Property, Plant and Equipment mean?
A high Property, Plant and Equipment can signal that a stock is expensive relative to its fundamentals. The total property, plant and equipment recorded on a company's balance sheet less accumulated depreciation. View historical data on CSPC Pharmaceutical Group and its competitors. CSPC Pharmaceutical Group's current Property, Plant and Equipment is $1,994 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CSPC Pharmaceutical Group stock overvalued right now?
Based on GuruFocus' analysis, CSPC Pharmaceutical Group (CSPCY) is currently considered Modestly Overvalued. The stock's GF Value™ is $3.16, compared to a current price of $3.84 — trading 21.5% above its estimated fair value. The current Property, Plant and Equipment is $1,994 Mil. CSPC Pharmaceutical Group's overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Property, Plant and Equipment calculated?
Property, Plant and Equipment is calculated from a company's financial statements. For CSPC Pharmaceutical Group (CSPCY), the current Property, Plant and Equipment is $1,994 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CSPC Pharmaceutical Group (CSPCY) Overvalued in 2026?

Based on GuruFocus' analysis, CSPC Pharmaceutical Group stock appears to be overvalued. The current stock price of $3.84 is trading 21.5% above its estimated GF Value™ of $3.16. GuruFocus considers CSPC Pharmaceutical Group to be Modestly Overvalued.

Key valuation signals for CSPCY:

  • Property, Plant and Equipment: $1,994 Mil
  • GF Value™: $3.16 vs. price of $3.84 (21.5% above fair value)
  • GF Score™: 78/100 with 4 warning signs

No single metric tells the full story. See the CSPCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CSPC Pharmaceutical Group Business Description

Address No.896 Zhongshandong Street, Gaoxin District, Hebei Province, Shijiazhuang, CHN, 050035
CSPC Pharmaceutical Group LTD is engaged in the manufacture and sale of pharmaceutical products. The group's segments include: Finished drugs, consisting research and development, manufacture and sale of pharmaceutical products and license fee income; Bulk products, that manufacture and sale of vitamin C, and antibiotic products in bulk powder form; and Functional food and others, that manufacture and sale of functional food products (including caffeine food additives, anhydrous glucose, acarbose and vitamin C buccal tablets), provision of healthcare service and others. It derives maximum revenue from Finished Products segments. Geographically, the company operates in Chinese Mainland, which Chinese Mainland generates maximum revenue; Other Asian regions; Europe; North America; and Others.
78GF Score

Get the complete analysis for CSPCY

Property, Plant and Equipment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.84
Price
$3.16
GF Value